Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 24;18(3):484.
doi: 10.3390/ijms18030484.

Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis

Affiliations
Review

Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis

Charles J Malemud. Int J Mol Sci. .

Abstract

Elevated levels of pro-inflammatory cytokines are generally thought to be responsible for driving the progression of synovial joint inflammation in rheumatoid arthritis (RA) and osteoarthritis (OA). These cytokines activate several signal transduction pathways, including the Janus kinase/Signal Transducers and Activators of Transcription (JAK/STAT), Stress-Activated/Mitogen-Activated Protein Kinase (SAPK/MAPK) and phosphatidylinositol-3-kinase/Akt/mechanistic target of rapamycin (PI3K/Akt/mTOR) pathways which regulate numerous cellular responses. However, cytokine gene expression, matrix metalloproteinase gene expression and aberrant immune cell and synoviocyte survival via reduced apoptosis are most critical in the context of inflammation characteristic of RA and OA. Negative regulation of JAK/STAT signaling is controlled by Suppressor of Cytokine Signaling (SOCS) proteins. SOCS is produced at lower levels in RA and OA. In addition, gaining further insight into the role played in RA and OA pathology by the inhibitors of the apoptosis protein family, cellular inhibitor of apoptosis protein-1, -2 (c-IAP1, c-IAP2), X (cross)-linked inhibitor of apoptosis protein (XIAP), protein inhibitor of activated STAT (PIAS), and survivin (human) as well as SOCS appears to be a worthy endeavor going forward.

Keywords: apoptosis; arthritis; chondrocytes.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

Cited by

References

    1. Miossec P. An update on the cytokine network in rheumatoid arthritis. Curr. Opin. Rheumatol. 2004;16:218–222. doi: 10.1097/00002281-200405000-00009. - DOI - PubMed
    1. Asquith D.L., McInnes I.B. Emerging cytokine targets in rheumatoid arthritis. Curr. Opin. Rheumatol. 2007;19:246–251. doi: 10.1097/BOR.0b013e3280eec78c. - DOI - PubMed
    1. Thompson C., Davies R., Choy E. Anti cytokine therapy in chronic inflammatory arthritis. Cytokine. 2016;86:92–99. doi: 10.1016/j.cyto.2016.07.015. - DOI - PubMed
    1. Mateen S., Zafar A., Moin S., Khan A.Q., Zubair S. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin. Chim. Acta. 2016;455:161–171. doi: 10.1016/j.cca.2016.02.010. - DOI - PubMed
    1. Upchurch K.S., Kay J. Evolution of treatment from rheumatoid arthritis. Rheumatology. 2012;6:vi28–vi36. - PubMed